The landscape of managing diabetes is changing with the arrival of skin-applied GLP-1 therapy. These convenient delivery systems offer a likely simpler alternative to injections for individuals dealing with diabetes 2. Such a system deliver a GLP-1 agonist directly through the skin , avoiding the need for regular injections and potentially improvin